Timing of Stoma Closure in Neonates: the ToSCiN mixed-methods study.

Graciaa Singhal, Madeleine Hurd, Gareth Penman, Tracy Mitchell, Elizabeth Deja, Nick Lansdale, Marian Knight, Chris Gale, Cheryl Battersby, Raphael Goldacre, Pollyanna Hardy, Kerry Woolfall, Kayleigh Stanbury, David Murray, Louise Linsell, Nigel Hall, Rema Ramakrishnan

Journal: Health technology assessment (Winchester, England) 2024;28(71):1-130

PMID: 39487601

Abstract

BACKGROUND

Neonates undergoing emergency abdominal surgery frequently require a stoma; closing this stoma with a second operation is an essential part of recovery. Timing of closure varies. Optimal timing is unclear and would be best resolved through a randomised controlled trial; such a trial is likely to be challenging.

AIM

To determine if it is feasible to conduct a clinical trial comparing 'early' versus 'late' stoma closure in neonates.

DESIGN

Mixed methods comprising three parallel workstreams incorporating: a clinician survey, prospective observational cohort study, parent interviews, focus groups, database analyses and consensus meeting.

SETTING

Specialist neonatal surgical centres across the United Kingdom.

PARTICIPANTS AND DATA SOURCES

Neonatologists, neonatal surgeons, neonatal dietitians and neonatal nurses who care for neonates with stomas. Neonates with recent stoma, their parents and the clinicians looking after them. Three existing, overlapping clinical databases.

RESULTS

One hundred and sixty-six professionals from all 27 neonatal surgical centres completed the survey: 6 weeks was the most common target time for stoma closure across clinical scenarios, although there was wide variation. Timing of closure was influenced by nutrition, growth and stoma complications. The prospective cohort study enrolled 56 infants from 8 centres. Infants were mostly preterm with necrotising enterocolitis or intestinal perforation. Clinicians identified extreme preterm gestation and clinical conditions as reasons for not randomising babies into a hypothetical trial comparing early and late stoma closure. Parents and healthcare professionals identified that comparator arms needed more clinical flexibility in relation to timing of stoma closure. Analysis of existing databases revealed wide variation in current timing of stoma closure in neonates and identified approximately 300 eligible infants for a trial per annum in the United Kingdom.

CONCLUSIONS

A trial of 'early' compared to 'late' stoma closure in neonates is feasible and is important to families and health professionals. The population of eligible babies in the United Kingdom is sufficient for such a trial. Challenges centre around lack of equipoise in certain scenarios, specifically: extremely preterm infants; infants waiting too long for stoma closure in the 'late' comparator; and logistical issues in closing a stoma at a trial-allocated time. These challenges are addressable by incorporating flexibility based on gestation at birth, communicating that both trial arms are standard practice and valid treatment options, and providing resources, for example, for operating lists.

FUTURE WORK

We recommend the following population, intervention, comparator and outcome as a starting point to inform future trial design. Population: neonates with stomas (excluding those with a fixed treatment pathway). Intervention: stoma closure at 6 weeks and after 32 weeks post conceptual age. Comparator: expectant management with stoma closure undertaken when the clinical team determines is best for the infant. Primary outcomes: weight gain/growth or length of hospital stay.

STUDY REGISTRATION

This study is registered as IRAS Project ID 278331, REC Reference 20/LO/1227.

FUNDING

This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR128617) and is published in full in ; Vol. 28, No. 71. See the NIHR Funding and Awards website for further award information.

Address: Department of Paediatric and Neonatal Surgery, Royal Manchester Children's Hospital, Manchester, UK.; Division of Developmental Biology and Medicine, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, UK.; Hull York Medical School, Hull, UK.; Unit of Health Care Epidemiology, Big Data Institute, University of Oxford, Oxford, UK.; Nuffield Department of Population Health, and NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.; National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; University Surgery Unit, University of Southampton, Southampton, UK.; Neonatal Medicine, School of Public Health, Imperial College London, London, UK.; Department of Neonatology, St Mary's Hospital, Manchester, UK.; National Perinatal Epidemiology Unit Clinical Trials Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.